HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephan Frank Selected Research

glycyltryptophan

1/2020Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [177Lu]Lu-PP-F11N.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephan Frank Research Topics

Disease

22Neoplasms (Cancer)
10/2022 - 03/2004
10Glioma (Gliomas)
01/2022 - 02/2014
5Alzheimer Disease (Alzheimer's Disease)
02/2022 - 07/2009
5Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2011
4Neurodegenerative Diseases (Neurodegenerative Disease)
02/2022 - 05/2013
3Frontotemporal Dementia (Semantic Dementia)
11/2018 - 07/2009
3Tauopathies
01/2018 - 07/2009
3Muscular Diseases (Myopathy)
01/2016 - 02/2013
2Brain Neoplasms (Brain Tumor)
01/2022 - 01/2018
2Primitive Neuroectodermal Tumors (PNET)
11/2021 - 02/2016
2Astrocytoma (Pilocytic Astrocytoma)
01/2021 - 04/2011
2Parkinson Disease (Parkinson's Disease)
01/2019 - 11/2018
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2016 - 05/2010
2Cognitive Dysfunction
06/2014 - 07/2009
2Muscular Dystrophies (Muscular Dystrophy)
06/2014 - 05/2010
2Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
04/2014 - 05/2010
2Dementia (Dementias)
02/2013 - 07/2009
1Meningioma (Meningiomas)
12/2021
1Carcinoma (Carcinomatosis)
05/2021
1Ependymoma
01/2021
1Insulinoma
01/2021
1Mesothelioma
01/2021
1Muscular Atrophy (Muscle Atrophy)
01/2021
1Mononeuropathies (Mononeuritis Multiplex)
01/2021
1Inflammation (Inflammations)
12/2020
1COVID-19
08/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Vulvitis
10/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2019
1Mitochondrial cytopathy
05/2019
1MELAS Syndrome (Syndrome, MELAS)
05/2019
1Necrosis
01/2019
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2018
1Demyelinating Diseases (Demyelinating Disease)
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2018
1Lymphoma (Lymphomas)
01/2018
1Myotonic Dystrophy (Dystrophia Myotonica)
02/2017

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
02/2022 - 05/2010
6Phosphotransferases (Kinase)IBA
01/2020 - 03/2011
5Mechanistic Target of Rapamycin Complex 1IBA
12/2021 - 05/2013
4RNA (Ribonucleic Acid)IBA
10/2022 - 01/2019
4Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2018
3PrionsIBA
02/2022 - 05/2013
3minigastrinIBA
12/2021 - 01/2020
3Radioisotopes (Radionuclides)IBA
11/2020 - 01/2016
2tau Proteins (tau Protein)IBA
02/2022 - 07/2009
2MethyltransferasesIBA
01/2022 - 12/2019
2Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 01/2016
2CytokinesIBA
01/2022 - 01/2018
2EverolimusFDA Link
12/2021 - 01/2020
2TOR Serine-Threonine KinasesIBA
12/2021 - 02/2014
2LipidsIBA
12/2020 - 01/2019
2Cholecystokinin B ReceptorIBA
11/2020 - 01/2020
2LigandsIBA
01/2020 - 01/2015
2Metformin (Glucophage)FDA LinkGeneric
01/2020 - 01/2016
2ProteomeIBA
12/2019 - 08/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
10/2019 - 01/2018
2Cisplatin (Platino)FDA LinkGeneric
10/2019 - 06/2010
2Immune Checkpoint InhibitorsIBA
10/2019 - 01/2017
2Mitochondrial Proteins (Mitochondrial Protein)IBA
11/2018 - 01/2016
2AntibodiesIBA
01/2017 - 05/2010
2Protein Isoforms (Isoforms)IBA
09/2013 - 05/2013
1hydrogen sulfite (bisulfite)IBA
01/2022
1Alkylating AgentsIBA
01/2022
1InterferonsIBA
01/2022
1larotrectinibIBA
01/2022
1Retinaldehyde (Retinal)IBA
11/2021
1Nuclear Proteins (Protein, Nuclear)IBA
05/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1eIF-4BIBA
01/2021
1pembrolizumabIBA
01/2021
1Biological ProductsIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1GlucocorticoidsIBA
01/2021
1Casein Kinase II (Casein Kinase 2)IBA
01/2021
1Actinium-225IBA
11/2020
1PregnenoloneIBA
10/2020
1Blood Group Antigens (Blood Groups)IBA
08/2020
1glycyltryptophanIBA
01/2020
1aspartyl-phenylalanine (aspartylphenylalanine)IBA
01/2020
1Peptide Receptors (Peptide Receptor)IBA
01/2020
1alanyltyrosineIBA
01/2020
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2020
15-Methylcytosine (5 Methylcytosine)IBA
12/2019
1EnzymesIBA
12/2019
1Bevacizumab (Avastin)FDA Link
10/2019
1NivolumabIBA
10/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2019
1tyrosine receptor (receptor, tyrosine)IBA
08/2019
1Mitochondrial DNA (mtDNA)IBA
05/2019
1SOXB1 Transcription FactorsIBA
01/2019
1SynucleinsIBA
01/2019
1fibroblast growth factor 21IBA
01/2018
1SteroidsIBA
01/2018
1Protein Kinases (Protein Kinase)IBA
02/2017

Therapy/Procedure

6Therapeutics
01/2022 - 01/2016
3Drug Therapy (Chemotherapy)
10/2019 - 08/2012
3Radiotherapy
01/2016 - 06/2010
1Immunotherapy
10/2019